Featured Press Release
-
10/7/19 6:50 am EDTWOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) today announced that its marketing partner SymBio Pharmaceuticals Limited (“SymBio”) has submitted a New Drug Application (“NDA”) for TREAKISYM ready-to-dilute (“RTD”) liquid formulation in Japan. The NDA covers all indications for which TREAKISYM is currently approved (low-grade non-Hodgkin’s lymphoma, mantle cell lymphoma, and chronic lymphocytic leukemia). SymBio expects to launchSee More
-
9/23/19 4:30 pm EDTWOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) announced today that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at the 2019 Cantor Global Healthcare Conference as follows: Date: Wednesday, October 2, 2019 Time: 7:45 a.m. Eastern Daylight Time Location: Intercontinental New York Barclay Hotel, NYC Webcast: http://wsw.com/webcast/cantor10/egrx/ The presentation will be webcastSee More
-
8/28/19 4:30 pm EDTWOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) announced today that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at the Morgan Stanley 17th Annual Global Healthcare Conference as follows: Date: Wednesday, September 11, 2019 Time: 9:20 a.m. Eastern Daylight Time Location: Grand Hyatt New York, NYC Webcast: https://cc.talkpoint.com/morg007/See More